Back

Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study

26 April 2024 (13:33 - 13:45)
Organised by: Logo
Congress Presentation Part of: Effectively managing cardiovascular risk in Type 2 diabetes Antidiabetic Pharmacotherapy Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Gary Tse

Hong Kong Metropolitan University, Hong Kong (China)

4 More presentations in this session

Presentation thumbnail
Quiz presentation
Doctor S. Gati (London, GB) Professor V. Vassiliou (Norwich, GB)
Slides Video
Presentation thumbnail
Effects of urinary tract infection and stopping sodium-glucose cotranspoter-2 inhibitors in patients with type 2 diabetes mellitus: a population-based study
Professor Y. Kai Hang (Shenzhen, CN)
Abstract Slides
Presentation thumbnail
Potentially avoidable hospitalizations for diabetes in Switzerland
Doctor K. Maung (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Combined effects of gamma-glutamyltransferase and high-sensitivity C-reactive protein on cardiovascular events in patients with diabetes and chronic coronary syndrome
Doctor T. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Effectively managing cardiovascular risk in Type 2 diabetes

The Event

Event poster

ESC Preventive Cardiology 2024

26 April 2024 13:33 CET
You may be interested in
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources